iPSC-Derived Cell Therapies Summit

The iPSC-Derived Cell Therapies Summit is dedicated to the challenges across disease indications which are limiting the clinical translation of iPSC (Induced pluripotent stem cells) based approaches for cell therapy, including lack of regulatory guidance, safety concerns with differentiation protocols and licensing issues.

The iPSC-Derived Cell Therapies Summit covers topics such as:

• Safety & Efficacy of iPSC-Derived Cells to Maximize Clinical Translation
• Clinical Case Studies
• Innovative Gene Engineering for Enhanced Persistency of iPSC-Derived Products
• Clinical Trial Strategy for Successful Clinical Outcome
• Early Manufacturing Considerations & Future Thoughts for Commercialization
• Optimizing Differentiation Protocols to Unveil the Full Potential of iPSCs

The iPSC-Derived Cell Therapies Summit brings together attendees from pharma, biotech and academia.